Explore how artificial intelligence and digital innovations are transforming sludge dewatering in wastewater systems, ...

Pivotal Phase 2 ALPHA3 Trial with Cemacabtagene Ansegedleucel (Cema-Cel) in First Line (1L) Consolidation in Large B-Cell Lymphoma (LBCL) ALPHA3 ...

It appears that President Donald Trump’s angry social media posts have once again landed him in hot water in the courts: A ...

Former Justice Department paralegal Sean Dunn, who went viral this summer for chucking a Subway sandwich at a Customs and ...

Recorded $31.1 Million in Revenue During the Three Months Ended September 30, 2025, Representing a 26% Increase From Comparable Period of 2024 ---- Multiple New Programs Signed ...

The Bulls N’ Bears ASX Runner of the Week is… Mont Royal Resources, after it exploded back from merger purgatory with a ...

RADNOR, Pa., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today reported its financial results for the third quarter of fiscal ...

Pure Global has announced the launch of AI Builder, a new platform designed to simplify and accelerate the process of registering medical devices across international markets. Built on deep expertise ...

The portfolio lagged the MSCI World Index in the period. Underperformance was driven by a combination of traditional factor ...

In a significant development, the Supreme Court revived the CBI's appeal before the Chhattisgarh High Court against the ...

Detailed price information for Eupraxia Pharmaceuticals Inc (EPRX-T) from The Globe and Mail including charting and trades.

Get the latest on ARK Fintech Innovation ETF (ARKF): see why its high growth and volatility suggest holding, not buying, and ...